
Jardimet XR5 mg+1000
Beximco Pharmaceuticals Ltd.
Empagliflozin + Metformin Hydrochloride is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus and more.
Empagliflozin + Metformin Hydrochloride is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus, in patients who are:
Some evidence for cardiovascular risk reduction (reduced cardiovascular death in patients with established cardiovascular disease) and renoprotective benefit (slower decline in kidney function/reduced progression of chronic kidney disease) has been demonstrated specifically for the empagliflozin component in dedicated outcome trials; this fixed-dose combination itself has not been separately studied for these outcomes, and any such benefit should be discussed with a physician on an individual basis.
Empagliflozin + Metformin Hydrochloride is not indicated for type 1 diabetes mellitus or diabetic ketoacidosis.
The dose of Empagliflozin + Metformin Hydrochloride must be individualized based on the patient's current antidiabetic regimen, glycemic response, renal function, and tolerability. Baseline renal function (eGFR) should be assessed before starting therapy and monitored periodically thereafter. See the separate dosage and administration fields below for detailed titration schedules and intake instructions.
Side effects of Empagliflozin + Metformin Hydrochloride reflect both component drugs:
Patients should seek prompt medical attention for any serious or persistent side effect. See precautions_and_warnings for detailed guidance on warning signs.
Empagliflozin + Metformin Hydrochloride is contraindicated in:
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.